Stocks · Health care · Pharmaceutical Preparations

Pacira BioSciences, Inc.

PCRX Clue Score50
United States Fiscal year ends December CIK 0001396814 Results filed 4 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Laura Brege
16 Aug 2024
Director
Buy
1,000
$12.81
$12.81K
Marcelo Bigal
16 Aug 2024
Director
Buy
1,512
$13.25
$20.03K
Michael J. Yang
14 Aug 2024
Director
Buy
2,000
$12.90
$25.80K
Marcelo Bigal
12 Aug 2024
Director
Buy
3,400
$12.01
$40.83K
Mark Froimson
12 Aug 2024
Director
Buy
1,400
$11.58
$16.21K
Frank D. Lee
12 Aug 2024
Chief Executive Officer
Buy
8,264
$12.10
$99.99K
Roy Winston
11 Mar 2020
Chief Clinical Officer
Buy
2,500
$36.50
$91.25K
Showing 250 of 361 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 404
Amendments (4/A) skipped 2
Filings about a different issuer 1
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 31
Sales straight out of an exercise 131
Sales at will 152
Transactions with no price 0
Shares from compensation/vesting 4,047,727
Sales filed before the plan box existed 125
History held since 10 Feb 2011